查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1862302

干细胞疗法：全球市场份额和排名、总收入和需求预测（2025-2031年）

Stem Cell Therapy - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 123 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

全球干细胞治疗市场预计在 2024 年达到 6.85 亿美元，预计到 2031 年将达到 23.73 亿美元，2025 年至 2031 年的复合年增长率为 19.7%。

干细胞疗法是指利用干细胞治疗或预防疾病。这些细胞可以分化成多种特化细胞，具有再生受损组织、调节免疫反应、恢復受损器官正常功能的潜力。其下游应用包括治疗神经退化性疾病、心血管疾病、自体免疫疾病、整形外科损伤和某些癌症。

由于再生医学需求不断增长以及细胞研究技术的进步，全球干细胞治疗市场正蓬勃发展。各国政府和私营部门都在积极投资临床试验、研究基础设施和商业化策略。帕金森氏症、第一型糖尿病和心臟衰竭等慢性退化性疾病发生率的上升，推动了干细胞疗法的应用。此外，患者和医疗专业人员对干细胞疗法潜力的认识不断提高，也加速了其临床应用。法律规范正在逐步完善，以适应干细胞研究的独特特点，但区域监管差距和伦理问题仍然是挑战。学术机构、生技公司和医院正在携手合作，将实验室研究成果转化为临床应用。持续创新可望将市场拓展至个人化医疗领域，特别是透过基因编辑技术和诱导性多功能干细胞（iPSCs）的整合。

本报告旨在对全球干细胞治疗市场进行全面分析，重点关注总收入、企业市场占有率和主要企业的排名，以及按地区/国家、类型和应用对干细胞治疗进行分析。

本报告基于2020年至2031年的历史数据和预测数据（以2024年为基准年），对干细胞治疗市场规模（按销售收入计）进行了估算和预测。报告采用定量和定性分析相结合的方法，旨在帮助读者制定业务/成长策略、评估竞争格局、分析自身在当前市场中的地位，并就干细胞治疗做出明智的商业决策。

市场区隔

公司

  • Medipost
  • Theracell Advanced Biotechnology
  • Nature Cell
  • Stempeutics
  • Regeneus
  • Bluebird bio, Inc
  • NIPRO
  • Kyowa Kirin
  • CorestemChemon Inc.
  • ANTEROGEN.CO., LTD.
  • Holostem
  • NuVasive
  • JCR Pharmaceutical
  • Pharmicell
  • Medi-post
  • Anterogen
  • Takeda（TiGenix）

按类型分類的细分市场

  • 异体干细胞治疗
  • 自体干细胞疗法

应用领域

  • 神经退化性疾病
  • 心血管疾病
  • 自体免疫疾病
  • 整形外科损伤
  • 癌症
  • 其他的

按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 韩国
    • 东南亚
    • 印度
    • 澳洲
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 荷兰
    • 北欧国家
    • 其他欧洲
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 其他拉丁美洲
  • 中东和非洲
    • 土耳其
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 其他中东和非洲地区

The global market for Stem Cell Therapy was estimated to be worth US$ 685 million in 2024 and is forecast to a readjusted size of US$ 2373 million by 2031 with a CAGR of 19.7% during the forecast period 2025-2031.

Stem cell therapy refers to the use of stem cells to treat or prevent a disease or condition. These cells can differentiate into various specialized cell types, offering potential for regenerating damaged tissues, modulating immune responses, and restoring normal function in affected organs. Downstream applications include treatment for neurodegenerative diseases, cardiovascular disorders, autoimmune conditions, orthopedic injuries, and certain cancers.

The global stem cell therapy market has been gaining momentum due to increasing demand for regenerative medicine and technological advancements in cell-based research. Governments and private sectors are actively investing in clinical trials, research infrastructure, and commercialization strategies. There is a rising incidence of chronic and degenerative diseases, such as Parkinson's disease, type 1 diabetes, and heart failure, which are driving the adoption of stem cell-based treatments. Moreover, increasing awareness among patients and healthcare professionals about the potential of stem cell therapy is accelerating clinical adoption. Regulatory frameworks are gradually evolving to accommodate the unique aspects of stem cell research, though regional disparities in regulation and ethical concerns still pose challenges. Academic institutions, biotechnology companies, and hospitals are collaborating to translate laboratory research into clinical applications. With continued innovation, the market is expected to expand into personalized medicine, particularly with the integration of gene editing technologies and induced pluripotent stem cells (iPSCs).

This report aims to provide a comprehensive presentation of the global market for Stem Cell Therapy, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Stem Cell Therapy by region & country, by Type, and by Application.

The Stem Cell Therapy market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Stem Cell Therapy.

Market Segmentation

By Company

  • Medipost
  • Theracell Advanced Biotechnology
  • Nature Cell
  • Stempeutics
  • Regeneus
  • Bluebird bio, Inc
  • NIPRO
  • Kyowa Kirin
  • CorestemChemon Inc.
  • ANTEROGEN.CO., LTD.
  • Holostem
  • NuVasive
  • JCR Pharmaceutical
  • Pharmicell
  • Medi-post
  • Anterogen
  • Takeda (TiGenix)

Segment by Type

  • Allogeneic Stem Cell Therapies
  • Autologous Stem Cell Therapies

Segment by Application

  • Neurodegenerative Diseases
  • Cardiovascular Disorders
  • Autoimmune Conditions
  • Orthopedic Injuries
  • Cancer
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Stem Cell Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Stem Cell Therapy in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Stem Cell Therapy in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Stem Cell Therapy Product Introduction
  • 1.2 Global Stem Cell Therapy Market Size Forecast (2020-2031)
  • 1.3 Stem Cell Therapy Market Trends & Drivers
    • 1.3.1 Stem Cell Therapy Industry Trends
    • 1.3.2 Stem Cell Therapy Market Drivers & Opportunity
    • 1.3.3 Stem Cell Therapy Market Challenges
    • 1.3.4 Stem Cell Therapy Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Stem Cell Therapy Players Revenue Ranking (2024)
  • 2.2 Global Stem Cell Therapy Revenue by Company (2020-2025)
  • 2.3 Key Companies Stem Cell Therapy Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Stem Cell Therapy Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Stem Cell Therapy
  • 2.6 Stem Cell Therapy Market Competitive Analysis
    • 2.6.1 Stem Cell Therapy Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Stem Cell Therapy Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Allogeneic Stem Cell Therapies
    • 3.1.2 Autologous Stem Cell Therapies
  • 3.2 Global Stem Cell Therapy Sales Value by Type
    • 3.2.1 Global Stem Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Stem Cell Therapy Sales Value, by Type (2020-2031)
    • 3.2.3 Global Stem Cell Therapy Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Neurodegenerative Diseases
    • 4.1.2 Cardiovascular Disorders
    • 4.1.3 Autoimmune Conditions
    • 4.1.4 Orthopedic Injuries
    • 4.1.5 Cancer
    • 4.1.6 Others
  • 4.2 Global Stem Cell Therapy Sales Value by Application
    • 4.2.1 Global Stem Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Stem Cell Therapy Sales Value, by Application (2020-2031)
    • 4.2.3 Global Stem Cell Therapy Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Stem Cell Therapy Sales Value by Region
    • 5.1.1 Global Stem Cell Therapy Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Stem Cell Therapy Sales Value by Region (2020-2025)
    • 5.1.3 Global Stem Cell Therapy Sales Value by Region (2026-2031)
    • 5.1.4 Global Stem Cell Therapy Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Stem Cell Therapy Sales Value, 2020-2031
    • 5.2.2 North America Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Stem Cell Therapy Sales Value, 2020-2031
    • 5.3.2 Europe Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Stem Cell Therapy Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Stem Cell Therapy Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Stem Cell Therapy Sales Value, 2020-2031
    • 5.5.2 South America Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Stem Cell Therapy Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Stem Cell Therapy Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Stem Cell Therapy Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Stem Cell Therapy Sales Value, 2020-2031
    • 6.3.2 United States Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Stem Cell Therapy Sales Value, 2020-2031
    • 6.4.2 Europe Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Stem Cell Therapy Sales Value, 2020-2031
    • 6.5.2 China Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Stem Cell Therapy Sales Value, 2020-2031
    • 6.6.2 Japan Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Stem Cell Therapy Sales Value, 2020-2031
    • 6.7.2 South Korea Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Stem Cell Therapy Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Stem Cell Therapy Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Stem Cell Therapy Sales Value, 2020-2031
    • 6.9.2 India Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Stem Cell Therapy Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Medipost
    • 7.1.1 Medipost Profile
    • 7.1.2 Medipost Main Business
    • 7.1.3 Medipost Stem Cell Therapy Products, Services and Solutions
    • 7.1.4 Medipost Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Medipost Recent Developments
  • 7.2 Theracell Advanced Biotechnology
    • 7.2.1 Theracell Advanced Biotechnology Profile
    • 7.2.2 Theracell Advanced Biotechnology Main Business
    • 7.2.3 Theracell Advanced Biotechnology Stem Cell Therapy Products, Services and Solutions
    • 7.2.4 Theracell Advanced Biotechnology Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Theracell Advanced Biotechnology Recent Developments
  • 7.3 Nature Cell
    • 7.3.1 Nature Cell Profile
    • 7.3.2 Nature Cell Main Business
    • 7.3.3 Nature Cell Stem Cell Therapy Products, Services and Solutions
    • 7.3.4 Nature Cell Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.3.5 Nature Cell Recent Developments
  • 7.4 Stempeutics
    • 7.4.1 Stempeutics Profile
    • 7.4.2 Stempeutics Main Business
    • 7.4.3 Stempeutics Stem Cell Therapy Products, Services and Solutions
    • 7.4.4 Stempeutics Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Stempeutics Recent Developments
  • 7.5 Regeneus
    • 7.5.1 Regeneus Profile
    • 7.5.2 Regeneus Main Business
    • 7.5.3 Regeneus Stem Cell Therapy Products, Services and Solutions
    • 7.5.4 Regeneus Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Regeneus Recent Developments
  • 7.6 Bluebird bio, Inc
    • 7.6.1 Bluebird bio, Inc Profile
    • 7.6.2 Bluebird bio, Inc Main Business
    • 7.6.3 Bluebird bio, Inc Stem Cell Therapy Products, Services and Solutions
    • 7.6.4 Bluebird bio, Inc Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Bluebird bio, Inc Recent Developments
  • 7.7 NIPRO
    • 7.7.1 NIPRO Profile
    • 7.7.2 NIPRO Main Business
    • 7.7.3 NIPRO Stem Cell Therapy Products, Services and Solutions
    • 7.7.4 NIPRO Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.7.5 NIPRO Recent Developments
  • 7.8 Kyowa Kirin
    • 7.8.1 Kyowa Kirin Profile
    • 7.8.2 Kyowa Kirin Main Business
    • 7.8.3 Kyowa Kirin Stem Cell Therapy Products, Services and Solutions
    • 7.8.4 Kyowa Kirin Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Kyowa Kirin Recent Developments
  • 7.9 CorestemChemon Inc.
    • 7.9.1 CorestemChemon Inc. Profile
    • 7.9.2 CorestemChemon Inc. Main Business
    • 7.9.3 CorestemChemon Inc. Stem Cell Therapy Products, Services and Solutions
    • 7.9.4 CorestemChemon Inc. Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.9.5 CorestemChemon Inc. Recent Developments
  • 7.10 ANTEROGEN.CO., LTD.
    • 7.10.1 ANTEROGEN.CO., LTD. Profile
    • 7.10.2 ANTEROGEN.CO., LTD. Main Business
    • 7.10.3 ANTEROGEN.CO., LTD. Stem Cell Therapy Products, Services and Solutions
    • 7.10.4 ANTEROGEN.CO., LTD. Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.10.5 ANTEROGEN.CO., LTD. Recent Developments
  • 7.11 Holostem
    • 7.11.1 Holostem Profile
    • 7.11.2 Holostem Main Business
    • 7.11.3 Holostem Stem Cell Therapy Products, Services and Solutions
    • 7.11.4 Holostem Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.11.5 Holostem Recent Developments
  • 7.12 NuVasive
    • 7.12.1 NuVasive Profile
    • 7.12.2 NuVasive Main Business
    • 7.12.3 NuVasive Stem Cell Therapy Products, Services and Solutions
    • 7.12.4 NuVasive Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.12.5 NuVasive Recent Developments
  • 7.13 JCR Pharmaceutical
    • 7.13.1 JCR Pharmaceutical Profile
    • 7.13.2 JCR Pharmaceutical Main Business
    • 7.13.3 JCR Pharmaceutical Stem Cell Therapy Products, Services and Solutions
    • 7.13.4 JCR Pharmaceutical Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.13.5 JCR Pharmaceutical Recent Developments
  • 7.14 Pharmicell
    • 7.14.1 Pharmicell Profile
    • 7.14.2 Pharmicell Main Business
    • 7.14.3 Pharmicell Stem Cell Therapy Products, Services and Solutions
    • 7.14.4 Pharmicell Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Pharmicell Recent Developments
  • 7.15 Medi-post
    • 7.15.1 Medi-post Profile
    • 7.15.2 Medi-post Main Business
    • 7.15.3 Medi-post Stem Cell Therapy Products, Services and Solutions
    • 7.15.4 Medi-post Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.15.5 Medi-post Recent Developments
  • 7.16 Anterogen
    • 7.16.1 Anterogen Profile
    • 7.16.2 Anterogen Main Business
    • 7.16.3 Anterogen Stem Cell Therapy Products, Services and Solutions
    • 7.16.4 Anterogen Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.16.5 Anterogen Recent Developments
  • 7.17 Takeda (TiGenix)
    • 7.17.1 Takeda (TiGenix) Profile
    • 7.17.2 Takeda (TiGenix) Main Business
    • 7.17.3 Takeda (TiGenix) Stem Cell Therapy Products, Services and Solutions
    • 7.17.4 Takeda (TiGenix) Stem Cell Therapy Revenue (US$ Million) & (2020-2025)
    • 7.17.5 Takeda (TiGenix) Recent Developments

8 Industry Chain Analysis

  • 8.1 Stem Cell Therapy Industrial Chain
  • 8.2 Stem Cell Therapy Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Stem Cell Therapy Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Stem Cell Therapy Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Stem Cell Therapy Market Trends
  • Table 2. Stem Cell Therapy Market Drivers & Opportunity
  • Table 3. Stem Cell Therapy Market Challenges
  • Table 4. Stem Cell Therapy Market Restraints
  • Table 5. Global Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Stem Cell Therapy Revenue Market Share by Company (2020-2025)
  • Table 7. Key Companies Stem Cell Therapy Manufacturing Base Distribution and Headquarters
  • Table 8. Key Companies Stem Cell Therapy Product Type
  • Table 9. Key Companies Time to Begin Mass Production of Stem Cell Therapy
  • Table 10. Global Stem Cell Therapy Companies Market Concentration Ratio (CR5 and HHI)
  • Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Stem Cell Therapy as of 2024)
  • Table 12. Mergers & Acquisitions, Expansion Plans
  • Table 13. Global Stem Cell Therapy Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 14. Global Stem Cell Therapy Sales Value by Type (2020-2025) & (US$ Million)
  • Table 15. Global Stem Cell Therapy Sales Value by Type (2026-2031) & (US$ Million)
  • Table 16. Global Stem Cell Therapy Sales Market Share in Value by Type (2020-2025)
  • Table 17. Global Stem Cell Therapy Sales Market Share in Value by Type (2026-2031)
  • Table 18. Global Stem Cell Therapy Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 19. Global Stem Cell Therapy Sales Value by Application (2020-2025) & (US$ Million)
  • Table 20. Global Stem Cell Therapy Sales Value by Application (2026-2031) & (US$ Million)
  • Table 21. Global Stem Cell Therapy Sales Market Share in Value by Application (2020-2025)
  • Table 22. Global Stem Cell Therapy Sales Market Share in Value by Application (2026-2031)
  • Table 23. Global Stem Cell Therapy Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 24. Global Stem Cell Therapy Sales Value by Region (2020-2025) & (US$ Million)
  • Table 25. Global Stem Cell Therapy Sales Value by Region (2026-2031) & (US$ Million)
  • Table 26. Global Stem Cell Therapy Sales Value by Region (2020-2025) & (%)
  • Table 27. Global Stem Cell Therapy Sales Value by Region (2026-2031) & (%)
  • Table 28. Key Countries/Regions Stem Cell Therapy Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 29. Key Countries/Regions Stem Cell Therapy Sales Value, (2020-2025) & (US$ Million)
  • Table 30. Key Countries/Regions Stem Cell Therapy Sales Value, (2026-2031) & (US$ Million)
  • Table 31. Medipost Basic Information List
  • Table 32. Medipost Description and Business Overview
  • Table 33. Medipost Stem Cell Therapy Products, Services and Solutions
  • Table 34. Revenue (US$ Million) in Stem Cell Therapy Business of Medipost (2020-2025)
  • Table 35. Medipost Recent Developments
  • Table 36. Theracell Advanced Biotechnology Basic Information List
  • Table 37. Theracell Advanced Biotechnology Description and Business Overview
  • Table 38. Theracell Advanced Biotechnology Stem Cell Therapy Products, Services and Solutions
  • Table 39. Revenue (US$ Million) in Stem Cell Therapy Business of Theracell Advanced Biotechnology (2020-2025)
  • Table 40. Theracell Advanced Biotechnology Recent Developments
  • Table 41. Nature Cell Basic Information List
  • Table 42. Nature Cell Description and Business Overview
  • Table 43. Nature Cell Stem Cell Therapy Products, Services and Solutions
  • Table 44. Revenue (US$ Million) in Stem Cell Therapy Business of Nature Cell (2020-2025)
  • Table 45. Nature Cell Recent Developments
  • Table 46. Stempeutics Basic Information List
  • Table 47. Stempeutics Description and Business Overview
  • Table 48. Stempeutics Stem Cell Therapy Products, Services and Solutions
  • Table 49. Revenue (US$ Million) in Stem Cell Therapy Business of Stempeutics (2020-2025)
  • Table 50. Stempeutics Recent Developments
  • Table 51. Regeneus Basic Information List
  • Table 52. Regeneus Description and Business Overview
  • Table 53. Regeneus Stem Cell Therapy Products, Services and Solutions
  • Table 54. Revenue (US$ Million) in Stem Cell Therapy Business of Regeneus (2020-2025)
  • Table 55. Regeneus Recent Developments
  • Table 56. Bluebird bio, Inc Basic Information List
  • Table 57. Bluebird bio, Inc Description and Business Overview
  • Table 58. Bluebird bio, Inc Stem Cell Therapy Products, Services and Solutions
  • Table 59. Revenue (US$ Million) in Stem Cell Therapy Business of Bluebird bio, Inc (2020-2025)
  • Table 60. Bluebird bio, Inc Recent Developments
  • Table 61. NIPRO Basic Information List
  • Table 62. NIPRO Description and Business Overview
  • Table 63. NIPRO Stem Cell Therapy Products, Services and Solutions
  • Table 64. Revenue (US$ Million) in Stem Cell Therapy Business of NIPRO (2020-2025)
  • Table 65. NIPRO Recent Developments
  • Table 66. Kyowa Kirin Basic Information List
  • Table 67. Kyowa Kirin Description and Business Overview
  • Table 68. Kyowa Kirin Stem Cell Therapy Products, Services and Solutions
  • Table 69. Revenue (US$ Million) in Stem Cell Therapy Business of Kyowa Kirin (2020-2025)
  • Table 70. Kyowa Kirin Recent Developments
  • Table 71. CorestemChemon Inc. Basic Information List
  • Table 72. CorestemChemon Inc. Description and Business Overview
  • Table 73. CorestemChemon Inc. Stem Cell Therapy Products, Services and Solutions
  • Table 74. Revenue (US$ Million) in Stem Cell Therapy Business of CorestemChemon Inc. (2020-2025)
  • Table 75. CorestemChemon Inc. Recent Developments
  • Table 76. ANTEROGEN.CO., LTD. Basic Information List
  • Table 77. ANTEROGEN.CO., LTD. Description and Business Overview
  • Table 78. ANTEROGEN.CO., LTD. Stem Cell Therapy Products, Services and Solutions
  • Table 79. Revenue (US$ Million) in Stem Cell Therapy Business of ANTEROGEN.CO., LTD. (2020-2025)
  • Table 80. ANTEROGEN.CO., LTD. Recent Developments
  • Table 81. Holostem Basic Information List
  • Table 82. Holostem Description and Business Overview
  • Table 83. Holostem Stem Cell Therapy Products, Services and Solutions
  • Table 84. Revenue (US$ Million) in Stem Cell Therapy Business of Holostem (2020-2025)
  • Table 85. Holostem Recent Developments
  • Table 86. NuVasive Basic Information List
  • Table 87. NuVasive Description and Business Overview
  • Table 88. NuVasive Stem Cell Therapy Products, Services and Solutions
  • Table 89. Revenue (US$ Million) in Stem Cell Therapy Business of NuVasive (2020-2025)
  • Table 90. NuVasive Recent Developments
  • Table 91. JCR Pharmaceutical Basic Information List
  • Table 92. JCR Pharmaceutical Description and Business Overview
  • Table 93. JCR Pharmaceutical Stem Cell Therapy Products, Services and Solutions
  • Table 94. Revenue (US$ Million) in Stem Cell Therapy Business of JCR Pharmaceutical (2020-2025)
  • Table 95. JCR Pharmaceutical Recent Developments
  • Table 96. Pharmicell Basic Information List
  • Table 97. Pharmicell Description and Business Overview
  • Table 98. Pharmicell Stem Cell Therapy Products, Services and Solutions
  • Table 99. Revenue (US$ Million) in Stem Cell Therapy Business of Pharmicell (2020-2025)
  • Table 100. Pharmicell Recent Developments
  • Table 101. Medi-post Basic Information List
  • Table 102. Medi-post Description and Business Overview
  • Table 103. Medi-post Stem Cell Therapy Products, Services and Solutions
  • Table 104. Revenue (US$ Million) in Stem Cell Therapy Business of Medi-post (2020-2025)
  • Table 105. Medi-post Recent Developments
  • Table 106. Anterogen Basic Information List
  • Table 107. Anterogen Description and Business Overview
  • Table 108. Anterogen Stem Cell Therapy Products, Services and Solutions
  • Table 109. Revenue (US$ Million) in Stem Cell Therapy Business of Anterogen (2020-2025)
  • Table 110. Anterogen Recent Developments
  • Table 111. Takeda (TiGenix) Basic Information List
  • Table 112. Takeda (TiGenix) Description and Business Overview
  • Table 113. Takeda (TiGenix) Stem Cell Therapy Products, Services and Solutions
  • Table 114. Revenue (US$ Million) in Stem Cell Therapy Business of Takeda (TiGenix) (2020-2025)
  • Table 115. Takeda (TiGenix) Recent Developments
  • Table 116. Key Raw Materials Lists
  • Table 117. Raw Materials Key Suppliers Lists
  • Table 118. Stem Cell Therapy Downstream Customers
  • Table 119. Stem Cell Therapy Distributors List
  • Table 120. Research Programs/Design for This Report
  • Table 121. Key Data Information from Secondary Sources
  • Table 122. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Stem Cell Therapy Product Picture
  • Figure 2. Global Stem Cell Therapy Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Stem Cell Therapy Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Stem Cell Therapy Report Years Considered
  • Figure 5. Global Stem Cell Therapy Players Revenue Ranking (2024) & (US$ Million)
  • Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Stem Cell Therapy Revenue in 2024
  • Figure 7. Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 8. Allogeneic Stem Cell Therapies Picture
  • Figure 9. Autologous Stem Cell Therapies Picture
  • Figure 10. Global Stem Cell Therapy Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 11. Global Stem Cell Therapy Sales Value Market Share by Type, 2024 & 2031
  • Figure 12. Product Picture of Neurodegenerative Diseases
  • Figure 13. Product Picture of Cardiovascular Disorders
  • Figure 14. Product Picture of Autoimmune Conditions
  • Figure 15. Product Picture of Orthopedic Injuries
  • Figure 16. Product Picture of Cancer
  • Figure 17. Product Picture of Others
  • Figure 18. Global Stem Cell Therapy Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 19. Global Stem Cell Therapy Sales Value Market Share by Application, 2024 & 2031
  • Figure 20. North America Stem Cell Therapy Sales Value (2020-2031) & (US$ Million)
  • Figure 21. North America Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • Figure 22. Europe Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 23. Europe Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • Figure 24. Asia Pacific Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 25. Asia Pacific Stem Cell Therapy Sales Value by Region (%), 2024 VS 2031
  • Figure 26. South America Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 27. South America Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Middle East & Africa Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Middle East & Africa Stem Cell Therapy Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Key Countries/Regions Stem Cell Therapy Sales Value (%), (2020-2031)
  • Figure 31. United States Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 32. United States Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 33. United States Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 34. Europe Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Europe Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 36. Europe Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 37. China Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 38. China Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 39. China Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 40. Japan Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 41. Japan Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 42. Japan Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 43. South Korea Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 44. South Korea Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 45. South Korea Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 46. Southeast Asia Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 47. Southeast Asia Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 48. Southeast Asia Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 49. India Stem Cell Therapy Sales Value, (2020-2031) & (US$ Million)
  • Figure 50. India Stem Cell Therapy Sales Value by Type (%), 2024 VS 2031
  • Figure 51. India Stem Cell Therapy Sales Value by Application (%), 2024 VS 2031
  • Figure 52. Stem Cell Therapy Industrial Chain
  • Figure 53. Stem Cell Therapy Manufacturing Cost Structure
  • Figure 54. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 55. Bottom-up and Top-down Approaches for This Report
  • Figure 56. Data Triangulation
  • Figure 57. Key Executives Interviewed